Cargando…
Protocol for an open-label feasibility study for a randomised controlled trial of vitamin D supplementation in Crohn’s Disease patients with vitamin D deficiency: D-CODE Feasiblity study
BACKGROUND: Crohn's disease (CD) is a principal form of inflammatory bowel disease, affecting approximately 1 in every 650 people in the UK. Vitamin D deficiency is common in approximately 57.7% of CD patients; with anaemia occurring in about 43% of patients. There is growing evidence that supp...
Autores principales: | Fletcher, Jane, Bedson, Emma, Brown, Michaela, Hewison, Martin, Swift, Amelia, Cooper, Sheldon C. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7980629/ https://www.ncbi.nlm.nih.gov/pubmed/33743801 http://dx.doi.org/10.1186/s40814-021-00813-3 |
Ejemplares similares
-
Screening and Treatment of Vitamin D Deficiency in UK Patients with Crohn’s Disease: Self-Reported Practice among Gastroenterologists
por: Fletcher, Jane, et al.
Publicado: (2020) -
Autoimmune disease and interconnections with vitamin D
por: Fletcher, Jane, et al.
Publicado: (2022) -
The Role of Vitamin D in Inflammatory Bowel Disease: Mechanism to Management
por: Fletcher, Jane, et al.
Publicado: (2019) -
Are Systematic Screening for Vitamin D Deficiency and Vitamin D Supplementation Currently Feasible for Ankylosing Spondylitis Patients?
por: Essouma, Mickael, et al.
Publicado: (2017) -
Therapeutic Effect of Vitamin D Supplementation in a Pilot Study of Crohn's Patients
por: Yang, Linlin, et al.
Publicado: (2013)